What is Fight Aging! and what does the site cover?

Updated

Fight Aging! (fightaging.org) is a news and commentary site focused on the science of rejuvenation biotechnology and advocacy for longer, healthier lives. It is aimed at readers who want ongoing, opinionated coverage of aging research and the longevity industry rather than general health or lifestyle content. If you are looking for a running feed of research summaries, industry developments, and critical commentary on how aging science is framed, this site is built for that purpose.

What the site is about

The site's own description is "The science of rejuvenation biotechnology. Advocacy for longer, healthier lives." In practice, that means:

  • Rejuvenation biotechnology — research and therapies aimed at repairing or reversing the biological damage of aging, not just managing individual age-related diseases.
  • Longevity science — the biology of aging, including conserved molecular pathways that can be modulated pharmacologically.
  • Advocacy — a stated position that aging should be treated as a target for medical intervention, and that longer, healthier lives are a goal worth pursuing.

What kind of content you will find

The site publishes articles and commentary, often built around open-access research and reviews. From the page evidence, recent items include:

Topic What it illustrates
A conservative view of the geroscience endeavor Commentary on how academia and industry judge whether aging can be slowed or reversed
Engineering better therapeutic delivery of mitochondria Research-oriented coverage of delivery approaches
Geomagnetic field effects on mitochondrial function Coverage of less conventional biological influences
mTOR as a pharmaceutical target Argument that context matters, rather than treating a pathway as one simple target
Catestatin and tau pathology in mice Preclinical findings relevant to neurodegeneration

The excerpt also shows the site's editorial voice: it argues that lumping very different approaches under one "longevity industry" heading is a category error. It contrasts NAD+ upregulation (described as having unreliable animal data, small effect size, and failed human trials) with senolytics (described as having reliable and extensive animal data and large effect size for reversing age-related conditions). That kind of evidence-weighted comparison is characteristic of the site's commentary.

Who it is for

  • Readers who want to follow aging research and the longevity industry at a level between press releases and primary papers.
  • People interested in rejuvenation biotechnology as a field, including its scientific debates and its advocacy side.
  • Anyone trying to judge how strong the evidence is for different proposed anti-aging approaches, since the site frequently compares evidence quality across therapies.

What to expect in tone and scope

The content is explanatory and argumentative rather than neutral news reporting. It takes positions — for example, that aging can potentially be slowed or reversed in humans as it has been in laboratory species, and that waiting for certainty before participating is not how victories are won. It also critiques how the field and industry categorize their own work.

If you want a site that treats aging as a medical problem to be solved and comments critically on the science and business around that goal, Fight Aging! matches that description. If you want neutral, broad health coverage or clinical guidance, this is not that kind of source.